Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 1
2009 1
2011 2
2014 1
2015 2
2016 7
2017 1
2018 1
2019 2
2020 2
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
How should we be using biomarkers in trials of disease modification in Parkinson's disease?
Vijiaratnam N, Foltynie T. Vijiaratnam N, et al. Brain. 2023 Dec 1;146(12):4845-4869. doi: 10.1093/brain/awad265. Brain. 2023. PMID: 37536279 Free PMC article.
The recent validation of the alpha-synuclein seed amplification assay as a biomarker with high sensitivity and specificity for the diagnosis of Parkinson's disease has formed the backbone for a proposed staging system for incorporation in Parkinson' …
The recent validation of the alpha-synuclein seed amplification assay as a biomarker with high sensitivity and specificity for the diagnosis …
Health-Related Quality of Life in patients with Parkinson's disease--A systematic review based on the ICF model.
van Uem JM, Marinus J, Canning C, van Lummel R, Dodel R, Liepelt-Scarfone I, Berg D, Morris ME, Maetzler W. van Uem JM, et al. Neurosci Biobehav Rev. 2016 Feb;61:26-34. doi: 10.1016/j.neubiorev.2015.11.014. Epub 2015 Dec 2. Neurosci Biobehav Rev. 2016. PMID: 26645499 Review.
We analyzed features associated with a reduction in Health-Related Quality of Life (HRQoL) in people with idiopathic Parkinson's disease (PD). As a new approach, features were embedded in the WHO framework for measuring health and disability, the ICF model. . …
We analyzed features associated with a reduction in Health-Related Quality of Life (HRQoL) in people with idiopathic Parkinson's
Genetics of validated Parkinson's disease subtypes in the Oxford Discovery and Tracking Parkinson's cohorts.
Lawton M, Tan MM, Ben-Shlomo Y, Baig F, Barber T, Klein JC, Evetts SG, Millin S, Malek N, Grosset K, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood N, Grosset DG, Hu MT. Lawton M, et al. J Neurol Neurosurg Psychiatry. 2022 Jun 22;93(9):952-9. doi: 10.1136/jnnp-2021-327376. Online ahead of print. J Neurol Neurosurg Psychiatry. 2022. PMID: 35732412 Free PMC article.
OBJECTIVES: To explore the genetics of four Parkinson's disease (PD) subtypes that have been previously described in two large cohorts of patients with recently diagnosed PD. ...We also carried out a Genome-Wide Association Study (GWAS) of belonging to a subt …
OBJECTIVES: To explore the genetics of four Parkinson's disease (PD) subtypes that have been previously described in tw …
Connexin43- and Pannexin-Based Channels in Neuroinflammation and Cerebral Neuropathies.
Sarrouilhe D, Dejean C, Mesnil M. Sarrouilhe D, et al. Front Mol Neurosci. 2017 Oct 10;10:320. doi: 10.3389/fnmol.2017.00320. eCollection 2017. Front Mol Neurosci. 2017. PMID: 29066951 Free PMC article. Review.
Over recent years, evidence has accumulated supporting a link between inflammation and cerebral neuropathies (migraine, Alzheimer's disease (AD), Parkinson's disease (PD), major depressive disorder, autism spectrum disorder (ASD), epilepsy, schizophren …
Over recent years, evidence has accumulated supporting a link between inflammation and cerebral neuropathies (migraine, Alzheimer's disea
A Room with a View.
Washburn J. Washburn J. Am J Nurs. 2016 Apr;116(4):72. doi: 10.1097/01.NAJ.0000482151.82822.fe. Am J Nurs. 2016. PMID: 27011147
The Parkinson's Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson's Disease in Patients and their Carers.
Tolosa E, Ebersbach G, Ferreira JJ, Rascol O, Antonini A, Foltynie T, Gibson R, Magalhaes D, Rocha JF, Lees A. Tolosa E, et al. J Parkinsons Dis. 2021;11(3):1309-1323. doi: 10.3233/JPD-212611. J Parkinsons Dis. 2021. PMID: 34024784 Free PMC article.
BACKGROUND: A greater understanding of the everyday experiences of people with Parkinson's disease (PD) and their carers may help improve clinical practice. ...METHODS: PRISM is an observational cross-sectional study, in which people with PD and their carers …
BACKGROUND: A greater understanding of the everyday experiences of people with Parkinson's disease (PD) and their carer …
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease.
Epstein M, Johnson DA, Hawes R, Schmulewitz N, Vanagunas AD, Gossen ER, Robieson WZ, Eaton S, Dubow J, Chatamra K, Benesh J. Epstein M, et al. Clin Transl Gastroenterol. 2016 Mar 31;7(3):e159. doi: 10.1038/ctg.2016.19. Clin Transl Gastroenterol. 2016. PMID: 27030949 Free PMC article.
Levodopa-carbidopa intestinal gel (LCIG, also known in US as carbidopa-levodopa enteral suspension, CLES) is continuously infused directly to the proximal small intestine via PEG-J in patients with advanced Parkinson's disease (PD) to overcome slow and errati …
Levodopa-carbidopa intestinal gel (LCIG, also known in US as carbidopa-levodopa enteral suspension, CLES) is continuously infused directly t …
Rapid picture naming in Parkinson's disease using the Mobile Universal Lexicon Evaluation System (MULES).
Conway J, Ilardi M, Gonzalez C, Dahan N, Fallon S, Moehringer N, Hasanaj L, Joseph B, Serrano L, Rizzo JR, Rucker JC, Feigin A, Frucht S, Galetta SL, Balcer LJ. Conway J, et al. J Neurol Sci. 2020 Mar 15;410:116680. doi: 10.1016/j.jns.2020.116680. Epub 2020 Jan 9. J Neurol Sci. 2020. PMID: 31945624
MULES performance is slower in concussion and multiple sclerosis, conditions in which vision dysfunction is common. Visual aspects captured by the MULES may be impaired in Parkinson's disease (PD) including color discrimination, object recognition, visual pro …
MULES performance is slower in concussion and multiple sclerosis, conditions in which vision dysfunction is common. Visual aspects captured …
Neuropsychological deficits associated with driving performance in Parkinson's and Alzheimer's disease.
Grace J, Amick MM, D'Abreu A, Festa EK, Heindel WC, Ott BR. Grace J, et al. J Int Neuropsychol Soc. 2005 Oct;11(6):766-75. doi: 10.1017/S1355617705050848. J Int Neuropsychol Soc. 2005. PMID: 16248912 Free PMC article.
Neuropsychological and motor deficits in Parkinson's disease that may contribute to driving impairment were examined in a cohort study comparing patients with Parkinson's disease (PD) to patients with Alzheimer's disease (AD) and t …
Neuropsychological and motor deficits in Parkinson's disease that may contribute to driving impairment were examined in …
24 results